CVS Health (CVS) PT Raised to $113 at RBC Capital

July 9, 2026 7:27 AM

RBC Capital analyst Ben Hendrix raised the price target on CVS Health (NYSE: CVS) to $113.00 (from $107.00) while maintaining a Outperform rating.

No results found